SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Collectively, these results show that liraglutide reduces seizure susceptibility and cognitive dysfunction in the mouse model of Dravet syndrome, and exerts anti-apoptotic and neuroprotective effects in Scn1a KO mice and cells.